Profile for Japan Patent: 2023100646
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2023100646
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 16, 2037 | Lantheus Medcl | DEFINITY | perflutren |
| ⤷ Start Trial | Mar 16, 2037 | Lantheus Medcl | DEFINITY RT | perflutren |
| ⤷ Start Trial | Mar 16, 2037 | Lantheus Medcl | DEFINITY | perflutren |
| ⤷ Start Trial | Mar 16, 2037 | Lantheus Medcl | DEFINITY RT | perflutren |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
